Lv5
1170 积分 2021-08-09 加入
Advances in the management of pancreatic cancer
1个月前
已完结
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
1个月前
已完结
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
1个月前
已完结
Pancreatic cancer: Advances and challenges
1个月前
已完结
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection
1个月前
已完结
Therapeutic developments in pancreatic cancer
1个月前
已完结
Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming
1个月前
已完结
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
1个月前
已完结
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide
4个月前
已完结
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
6个月前
已完结
皖公网安备34019202002308
